The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Share News (VER)

  • There is currently no data for VER

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

10 Feb 2015 09:07

Vernalis Posts Narrowed Loss On Dollar Strength And Lower Costs

Read more
10 Feb 2015 06:16

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Feb 2015 16:13

REPEAT: UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Feb 2015 16:05

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Feb 2015 12:10

UK MIDDAY BRIEFING: Fewer Imports By World's Two Big Exporters

Read more
9 Feb 2015 06:15

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
6 Feb 2015 16:01

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
6 Feb 2015 06:17

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Feb 2015 16:00

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Feb 2015 06:24

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Feb 2015 15:58

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Feb 2015 06:15

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Feb 2015 16:00

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
19 Dec 2014 08:14

Vernalis shares stumble as Novartis abandons work on drug

LONDON, Dec 19 (Reuters) - Shares in Vernalis fell sharply on Friday as Swiss drugmaker Novartis stopped development work on a drug licensed from the British biotech company 10 years ago. Vernalis said Novartis had handed back rights to AUY922 after studying it as a treatment for a range of

Read more
14 Nov 2014 19:34

Friday broker round-up:

TSB Banking: Shore Capital reiterates buy with a target price for 325p. Vernalis: Canaccord Genuity ups target to 66p from 56p and reiterates buy. Aggreko: Panmure Gordon and Investec reiterate hold. Gemfields: Numis initiates coverage with a buy recommendation and 70p target price. Ithaca Energy

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.